News & Views | Published:

Stem cells

iPS cells under attack

Nature volume 474, pages 165166 (09 June 2011) | Download Citation

Induced pluripotent stem cells offer promise for patient-specific regenerative therapy. But a study now cautions that, even when immunologically matched, these cells can be rejected after transplantation. See Letter p.212

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    & Cell 126, 663–676 (2006).

  2. 2.

    & Genes Dev. 24, 2239–2263 (2010).

  3. 3.

    & Nature Cell Biol. 13, 497–505 (2011).

  4. 4.

    , , & Nature 474, 212–215 (2011).

  5. 5.

    et al. Nature 467, 285–290 (2010).

  6. 6.

    et al. Nature Biotechnol. 28, 848–855 (2010).

  7. 7.

    et al. Science 318, 1920–1923 (2007).

Download references

Author information


  1. Effie Apostolou and Konrad Hochedlinger are at the Howard Hughes Medical Institute, Center for Regenerative Medicine and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. They are also in the Department of Stem Cell and Regenerative Biology, and at the Harvard Stem Cell Institute, Harvard University.

    • Effie Apostolou
    •  & Konrad Hochedlinger


  1. Search for Effie Apostolou in:

  2. Search for Konrad Hochedlinger in:

Competing interests

K.H. is an adviser to iPerian, Inc.

Corresponding author

Correspondence to Konrad Hochedlinger.

About this article

Publication history




By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing